Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Carol Fabian"'
Autor:
Lori M. Minasian, MD, Eileen Dimond, RN, MS, Myrtle Davis, DVM, PhD, ATS, Bishow Adhikari, PhD, Richard Fagerstrom, PhD, Carol Fabian, MD, Justin Floyd, DO, Joseph M. Unger, PhD, MS, Pamela S. Douglas, MD, Karen M. Mustian, PhD, MPH, Eric J. Chow, MD, MPH, Steven Lipshultz, MD, W. Gregory Hundley, MD, Saro H. Armenian, DO, MPH, Bonnie Ky, MD, MSCE
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 1, Pp 105-113 (2019)
Cardiovascular (CV) toxicity from cancer therapy is a significant and growing concern. Conventional oncology clinical trial designs focused solely on cancer treatment efficacy have not provided sufficient information on both CV risk factors and outco
Externí odkaz:
https://doaj.org/article/c9974a1a47d043b78c7cfd5e8ff19334
Autor:
Anthony Rooney, Priyanka Sharma, Anne P O'Dea, Lauren Nye, Manana Elia, Jianghua He, Carol Fabian, Qamar Khan
Publikováno v:
Cancer Research. 82:P2-13
Background: Targeted agents against HER2 have been a cornerstone of the treatment armamentarium for HER2 positive breast cancer since the approval of trastuzumab by the FDA in 1998 for metastatic HER2 positive breast cancer. However, many patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::056b414a34c303d146acb4bed1fa946a
https://doi.org/10.1158/1538-7445.sabcs21-p2-13-34
https://doi.org/10.1158/1538-7445.sabcs21-p2-13-34
Autor:
Fariba Behbod, Carol Fabian, Andrew K. Godwin, Christy R. Hagan, Dean P. Edwards, Susan Hilsenbeck, Onalisa Winblad, Jason Gatewood, Mark Redick, Marc Inciardi, Therese Cusick, Lisa May, Ossama Tawfik, Fang Fan, Lawrence R. Ricci, Sandra L. Grimm, Yan Hong, Kelli E. Valdez, Hanan S. Elsarraj
NEMO KD results in increased cell survival and proliferation in MCF7 cells in vitro.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb2a6e45537879e6b33831645b67152
https://doi.org/10.1158/0008-5472.22415256.v1
https://doi.org/10.1158/0008-5472.22415256.v1
Autor:
Fariba Behbod, Carol Fabian, Andrew K. Godwin, Christy R. Hagan, Dean P. Edwards, Susan Hilsenbeck, Onalisa Winblad, Jason Gatewood, Mark Redick, Marc Inciardi, Therese Cusick, Lisa May, Ossama Tawfik, Fang Fan, Lawrence R. Ricci, Sandra L. Grimm, Yan Hong, Kelli E. Valdez, Hanan S. Elsarraj
The beneficial versus detrimental roles of estrogen plus progesterone (E+P) in breast cancer remains controversial. Here we report a beneficial mechanism of E+P treatment in breast cancer cells driven by transcriptional upregulation of the NFκB modu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74c26e42d7f06de74e94995b85911be7
https://doi.org/10.1158/0008-5472.c.6509211.v1
https://doi.org/10.1158/0008-5472.c.6509211.v1
Autor:
Fariba Behbod, Carol Fabian, Andrew K. Godwin, Christy R. Hagan, Dean P. Edwards, Susan Hilsenbeck, Onalisa Winblad, Jason Gatewood, Mark Redick, Marc Inciardi, Therese Cusick, Lisa May, Ossama Tawfik, Fang Fan, Lawrence R. Ricci, Sandra L. Grimm, Yan Hong, Kelli E. Valdez, Hanan S. Elsarraj
S1:Differences in response to E+P were not correlated with any available patient data, including biomarker expression, age, or nuclear grade. S2:ER target genes with a role in NFkB pathway.S3:Relapse-free survival (RFS), distant metastasis-free survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed793705cf040472b40cd49c413214b8
https://doi.org/10.1158/0008-5472.22415241.v1
https://doi.org/10.1158/0008-5472.22415241.v1
Autor:
Fariba Behbod, Carol Fabian, Andrew K. Godwin, Christy R. Hagan, Dean P. Edwards, Susan Hilsenbeck, Onalisa Winblad, Jason Gatewood, Mark Redick, Marc Inciardi, Therese Cusick, Lisa May, Ossama Tawfik, Fang Fan, Lawrence R. Ricci, Sandra L. Grimm, Yan Hong, Kelli E. Valdez, Hanan S. Elsarraj
Description of additional experiments and procedures carried out in this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06950546beca450ad3ff578b929f7dab
https://doi.org/10.1158/0008-5472.22415244.v1
https://doi.org/10.1158/0008-5472.22415244.v1
Autor:
Christie A, Befort, Jennifer R, Klemp, Debra K, Sullivan, Theresa, Shireman, Francisco J, Diaz, Kathryn, Schmitz, Michael G, Perri, Carol, Fabian
Publikováno v:
Obesity (Silver Spring, Md.). 24(10)
Obesity is a risk factor for breast cancer recurrence. Rural women have higher obesity rates compared with urban women and are in need of distance-based interventions that promote long-term weight loss.In this two-phase trial, rural breast cancer sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::093cca3e0783ce020834f043b6e689a8
https://pubmed.ncbi.nlm.nih.gov/27589365
https://pubmed.ncbi.nlm.nih.gov/27589365
Publikováno v:
Advances in experimental medicine and biology. 862
Obesity and low levels of physical activity are associated with a higher risk of breast cancer recurrence and mortality. Currently, over 65% of breast cancer survivors are overweight or obese, and fewer than 30% engage in recommended levels of physic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f73bd6b7486d1beac7a2ee65836e9ce7
https://pubmed.ncbi.nlm.nih.gov/26059937
https://pubmed.ncbi.nlm.nih.gov/26059937
Autor:
Carol, Fabian
Publikováno v:
Advances in experimental medicine and biology. 862
As recurrence free survival following a breast cancer diagnosis continues to improve, cardiovascular morbidity and mortality will assume greater importance in the breast cancer survivorship research agenda particularly for women receiving potentially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae3fe79bd6fb9de3d17bf7546950ac2f
https://pubmed.ncbi.nlm.nih.gov/26059938
https://pubmed.ncbi.nlm.nih.gov/26059938
Autor:
Carol, Fabian
Publikováno v:
The breast journal. 5(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf78a92b65c298f4bb9bb434952d1715
https://pubmed.ncbi.nlm.nih.gov/11348288
https://pubmed.ncbi.nlm.nih.gov/11348288